# Nehal J. Lakhani, M.D. – FDA Inspection, Nov 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/nehal-j-lakhani-md/b08ddfc6-638b-41f5-a65e-225633d17305
Source feed: FDA_Inspections

> FDA inspection 1222870 of Nehal J. Lakhani, M.D., November 17, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 50. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222870
- Company Name: Nehal J. Lakhani, M.D.
- Inspection Date: 2023-11-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)

Company: https://www.keypedia.com/companies/nehal-j-lakhani-md/cf16a0d3-6626-4ddf-8a99-a13799a85870

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
